Organovo Holdings Statistics

Total Valuation

Organovo Holdings has a market cap or net worth of GBP 4.46 million. The enterprise value is 2.83 million.

Market Cap	4.46M
Enterprise Value	2.83M

Important Dates

The next estimated earnings date is Friday, February 7, 2025.

Earnings Date	Feb 7, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+48.63%
Shares Change (QoQ)	+22.71%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	13.59M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	1.62
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-0.30
EV / Sales	33.89
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-0.32

Financial Position

The company has a current ratio of 1.98, with a Debt / Equity ratio of 0.32.

Current Ratio	1.98
Quick Ratio	1.33
Debt / Equity	0.32
Debt / EBITDA	n/a
Debt / FCF	-0.10
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -206.69% and return on invested capital (ROIC) is -107.04%.

Return on Equity (ROE)	-206.69%
Return on Assets (ROA)	-89.10%
Return on Capital (ROIC)	-107.04%
Revenue Per Employee	4,045
Profits Per Employee	-492,505
Employee Count	20
Asset Turnover	0.01
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -66.62% in the last 52 weeks. The beta is 0.61, so Organovo Holdings's price volatility has been lower than the market average.

Beta (5Y)	0.61
52-Week Price Change	-66.62%
50-Day Moving Average	0.46
200-Day Moving Average	1.16
Relative Strength Index (RSI)	44.49
Average Volume (20 Days)	2,310

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	0.25

Income Statement

In the last 12 months, Organovo Holdings had revenue of GBP 76,848 and -9.36 million in losses. Loss per share was -0.72.

Revenue	76,848
Gross Profit	-3.57M
Operating Income	-9.53M
Pretax Income	-9.36M
Net Income	-9.36M
EBITDA	-9.32M
EBIT	-9.53M
Loss Per Share	-0.72

Full Income Statement

Balance Sheet

The company has 2.37 million in cash and 875,175 in debt, giving a net cash position of 1.49 million.

Cash & Cash Equivalents	2.37M
Total Debt	875,175
Net Cash	1.49M
Net Cash Per Share	n/a
Equity (Book Value)	2.75M
Book Value Per Share	0.18
Working Capital	1.77M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -8.82 million and capital expenditures -9,699, giving a free cash flow of -8.83 million.

Operating Cash Flow	-8.82M
Capital Expenditures	-9,699
Free Cash Flow	-8.83M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-12,398.11%
Pretax Margin	-12,174.80%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Organovo Holdings does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-48.63%
Shareholder Yield	-48.63%
Earnings Yield	-209.86%
FCF Yield	-197.96%

Stock Splits

The last stock split was on August 19, 2020. It was a reverse split with a ratio of 0.05.

Last Split Date	Aug 19, 2020
Split Type	Reverse
Split Ratio	0.05

Scores

Organovo Holdings has an Altman Z-Score of -75.39. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-75.39
Piotroski F-Score	n/a